Get startedLog in
    Picture of Paradigm Biopharmaceuticals logo

    PAR — Paradigm Biopharmaceuticals News Story

    0.000.00%
    au flag iconLast trade - 00:00
    HealthcareSpeculativeSmall Cap
    All News

    Brief: Paradigm Biopharmaceuticals Posts FY Revenue From Continuing Activities A$8.8 Million

    Picture of Paradigm Biopharmaceuticals logoParadigm Biopharmaceuticals
    26/08/2022 02:15
    Aug 26 (Reuters) - Paradigm Biopharmaceuticals Ltd  PAR.AX :
    * FY REVENUE FROM CONTINUING ACTIVITIES A$8.8 MILLION
    * FY LOSS FROM CONTINUING ACTIVITIES AFTER TAX ATTRIBUTABLE
A$39.2
MILLION VERSUS PROFIT OF A$5 MILLION

Source text for Eikon:  ID:nASX67lpp0 
Further company coverage:  PAR.AX 

 ((Reuters.Briefs@thomsonreuters.com;))

    Recent news on Paradigm Biopharmaceuticals

    See all news